Latest News and Press Releases
Want to stay updated on the latest news?
-
ROCKVILLE, Md., June 1, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Biotest Pharmaceuticals Corporation has withdrawn and released a claim representing $50.4...
-
ROCKVILLE, Md., May 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced its first quarter financial results for the three month period ended March 28, 2009. The Company...
-
ROCKVILLE, Md., April 28, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2009 first quarter financial results on Wednesday, May 6, 2009, after...
-
ROCKVILLE, Md., April 1, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced today that its 2009 Annual Meeting of Shareholders will be held on Friday, May 22, 2009 at 10:00 a.m....
-
ROCKVILLE, Md., March 11, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced fourth quarter and year-end financial results for the three and twelve month periods ended...
-
Nabi Biopharmaceuticals to Present At the Noble Financial Capital Markets Boston Uncommon Conference
ROCKVILLE, Md., March 6, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that Dr. Raafat Fahim, President and Chief Executive Officer, will participate in the Noble...
-
ROCKVILLE, Md., March 5, 2009 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that it will report its 2008 fourth quarter and full-year financial results on Wednesday, March...
-
ROCKVILLE, Md., Dec. 23, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol...
-
ROCKVILLE, Md., Dec. 17, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) has entered into a Cooperative Research and Development Agreement (CRADA) with the Uniformed Services University...
-
ROCKVILLE, Md., Dec. 2, 2008 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) announced the receipt of two patents for key components of PentaStaph(tm), the Company's next-generations S....